Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05391022
What this trial is testing

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

Who this might be right for
Advanced MalignanciesSolid TumorHematological Malignancy
Constellation Pharmaceuticals 35
Large-scale testing (Phase 3)Active Not RecruitingNCT04089358
What this trial is testing

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 387
Early research (Phase 1)Study completedNCT04184869
What this trial is testing

Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

Who this might be right for
Solid TumorHematological Malignancies
Acrotech Biopharma Inc. 8
Not applicableUnknownNCT00710632
What this trial is testing

Screening to Predict Weight Loss in Patients With Cancer

Who this might be right for
CachexiaGastrointestinal CancerHematopoietic/Lymphoid Cancer+2 more
Queen's Medical Center 220
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04694911
What this trial is testing

Development of the Oncology Opportunity Cost Assessment Tool

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07570563
What this trial is testing

Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.

Who this might be right for
Hematologic MalignancySolid Tumor
Chinese PLA General Hospital 24
Testing effectiveness (Phase 2)Study completedNCT02717507
What this trial is testing

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 196
Testing effectiveness (Phase 2)UnknownNCT00750126
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Solid TumorsHematologic Neoplasms
University Hospital, Clermont-Ferrand 30
Not applicableEnded earlyNCT05012124
What this trial is testing

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

Who this might be right for
DepressionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of Washington 297
Not applicableStudy completedNCT05148806
What this trial is testing

Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies

Who this might be right for
Solid Organ Transplant RecipientsAutoimmune DiseasesHaematological Malignancies
Imperial College London 28,411
Not applicableStudy completedNCT00001397
What this trial is testing

Evaluation, Treatment, and Training for Patients With Blood Disorders

Who this might be right for
Hematologic Diseases
National Heart, Lung, and Blood Institute (NHLBI) 1,452
Not applicableNot Yet RecruitingNCT04871477
What this trial is testing

Adoption of Audio Recording in the Outpatient Supportive Care Center

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid Neoplasm+2 more
M.D. Anderson Cancer Center 200
Not applicableStudy completedNCT04826458
What this trial is testing

Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology

Who this might be right for
CancerSolid TumorHematologic Malignancy+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 124
Early research (Phase 1)Study completedNCT01351350
What this trial is testing

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesHematologic Malignancies
Millennium Pharmaceuticals, Inc. 68
Testing effectiveness (Phase 2)Ended earlyNCT02002689
What this trial is testing

LDE225 for Patients With PTCH1 or SMO Mutated Tumors

Who this might be right for
PTCH1 or SMO Activated Solid and Hematologic Tumors
Novartis Pharmaceuticals 10
Not applicableStudy completedNCT03087227
What this trial is testing

Shared Health Information System for Febrile Neutropenia

Who this might be right for
Febrile NeutropeniaSolid TumorHematologic Neoplasms
Marie-Helene METZGER 121
Not applicableStudy completedNCT04870320
What this trial is testing

Study of Attention and Memory Treatments for Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 49
Early research (Phase 1)Study completedNCT00387608
What this trial is testing

ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 23
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Next Page